BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Norton PA, Mehta AS. Expression of genes that control core fucosylation in hepatocellular carcinoma: Systematic review. World J Gastroenterol 2019; 25(23): 2947-2960 [PMID: 31249452 DOI: 10.3748/wjg.v25.i23.2947]
URL: https://www.wjgnet.com/1007-9327/full/v25/i23/2947.htm
Number Citing Articles
1
Songül Yaşar Yıldız. Computational Biology and Chemistry2020;  doi: 10.5772/intechopen.92267
2
Qiu Pan, Yan Xie, Ying Zhang, Xinqi Guo, Jing Wang, Min Liu, Xiao-Lian Zhang. EGFR core fucosylation, induced by hepatitis C virus, promotes TRIM40-mediated-RIG-I ubiquitination and suppresses interferon-I antiviral defensesNature Communications 2024; 15(1) doi: 10.1038/s41467-024-44960-6
3
Zhenzhen Liu, Zhentao Liu, Xin Zhou, Yongqu Lu, Yanhong Yao, Wendong Wang, Siyi Lu, Bingyan Wang, Fei Li, Wei Fu. A glycolysis-related two-gene risk model that can effectively predict the prognosis of patients with rectal cancerHuman Genomics 2022; 16(1) doi: 10.1186/s40246-022-00377-0
4
Mingchen Xie, Fuxu Wang, Bing Chen, Zeyu Wu, Ci Chen, Jian Xu. Systematic pan-cancer analysis identifies SLC35C1 as an immunological and prognostic biomarkerScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-32375-0
5
Nicholas J. G. Webster, Deepak Kumar, Panyisha Wu. Dysregulation of RNA splicing in early non-alcoholic fatty liver disease through hepatocellular carcinomaScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-52237-7
6
Joseph C. Gonzalez, Saborni Chakraborty, Natalie K. Thulin, Taia T. Wang. Heterogeneity in IgG‐CD16 signaling in infectious disease outcomes*Immunological Reviews 2022; 309(1): 64 doi: 10.1111/imr.13109
7
Mahdokht Kohansal-Nodehi, Magdalena Swiatek-de Lange, Konstantin Kroeniger, Vinzent Rolny, Glòria Tabarés, Teerha Piratvisuth, Tawesak Tanwandee, Satawat Thongsawat, Wattana Sukeepaisarnjaroen, Juan Ignacio Esteban, Marta Bes, Bruno Köhler, Henry Lik-Yuen Chan, Holger Busskamp. Discovery of a haptoglobin glycopeptides biomarker panel for early diagnosis of hepatocellular carcinomaFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1213898
8
Tanja Kunej. Rise of Systems Glycobiology and Personalized Glycomedicine: Why and How to Integrate Glycomics with Multiomics Science?OMICS: A Journal of Integrative Biology 2019; 23(12): 615 doi: 10.1089/omi.2019.0149
9
Naoyuki Taniguchi, Yuki Ohkawa, Kento Maeda, Yoichiro Harada, Masamichi Nagae, Yasuhiko Kizuka, Hideyuki Ihara, Yoshitaka Ikeda. True significance of N-acetylglucosaminyltransferases GnT-III, V and α1,6 fucosyltransferase in epithelial-mesenchymal transition and cancerMolecular Aspects of Medicine 2021; 79: 100905 doi: 10.1016/j.mam.2020.100905
10
Kayla Bastian, Emma Scott, David J. Elliott, Jennifer Munkley. FUT8 Alpha-(1,6)-Fucosyltransferase in CancerInternational Journal of Molecular Sciences 2021; 22(1): 455 doi: 10.3390/ijms22010455
11
Nian-Zhu Zhang, Li-Fen Zhao, Qian Zhang, Hui Fang, Wan-Li Song, Wen-Zhe Li, Yu-Song Ge, Peng Gao. Core fucosylation and its roles in gastrointestinal glycoimmunologyWorld Journal of Gastrointestinal Oncology 2023; 15(7): 1119-1134 doi: 10.4251/wjgo.v15.i7.1119
12
Caixia Liang, Wanli Song, Jianguo Gu. Glycosignals in Cancer2023; : 105 doi: 10.1007/978-981-19-7732-9_6
13
Jamal Manoochehri, Neda Kamal, Hossein Jafari Khamirani, Sina Zoghi, Maryam Fazelzadeh Haghighi, Hamed Reza Goodarzi, Seyed Mohammad Bagher Tabei. A combination of two novels homozygous FCSK variants cause disorder of glycosylation with defective fucosylation: New patient and literature reviewEuropean Journal of Medical Genetics 2022; 65(8): 104535 doi: 10.1016/j.ejmg.2022.104535
14
Roberto De Masi, Stefania Orlando. GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A ReviewInternational Journal of Molecular Sciences 2022; 23(13): 7373 doi: 10.3390/ijms23137373
15
Andrew T. DelaCourt, Anand S. Mehta. Comprehensive Pharmacology2022; : 112 doi: 10.1016/B978-0-12-820472-6.00007-4
16
Yuki Ohkawa, Yoichiro Harada, Naoyuki Taniguchi. Keratan sulfate-based glycomimetics using Langerin as a target for COPD: lessons from studies on Fut8 and core fucoseBiochemical Society Transactions 2021; 49(1): 441 doi: 10.1042/BST20200780
17
Andrew DelaCourt, Anand Mehta. Novel Methods and Pathways in Cancer Glycobiology ResearchAdvances in Cancer Research 2023; 157: 57 doi: 10.1016/bs.acr.2022.07.002
18
Ayesha Rahman, Lingadahalli S. Shashidhara. Analyzing the influence of IL18 in regulation of YAP1 in breast oncogenesis using cBioportalCancer Reports 2022; 5(3) doi: 10.1002/cnr2.1484
19
Gabriele Antonarelli, Valentina Pieri, Francesca Maria Porta, Nicola Fusco, Gaetano Finocchiaro, Giuseppe Curigliano, Carmen Criscitiello. Targeting Post-Translational Modifications to Improve Combinatorial Therapies in Breast Cancer: The Role of FucosylationCells 2023; 12(6): 840 doi: 10.3390/cells12060840
20
Mikel García-Alija, Berre van Moer, Diego E. Sastre, Tala Azzam, Jonathan J. Du, Beatriz Trastoy, Nico Callewaert, Eric J. Sundberg, Marcelo E. Guerin. Modulating antibody effector functions by Fc glycoengineeringBiotechnology Advances 2023; 67: 108201 doi: 10.1016/j.biotechadv.2023.108201
21
Emma Butaye, Nicky Somers, Lorenz Grossar, Nele Pauwels, Sander Lefere, Lindsey Devisscher, Sarah Raevens, Anja Geerts, Leander Meuris, Nico Callewaert, Hans Van Vlierberghe, Xavier Verhelst. Systematic review: Glycomics as diagnostic markers for hepatocellular carcinomaAlimentary Pharmacology & Therapeutics 2024; 59(1): 23 doi: 10.1111/apt.17748